This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Blogging Remove Conference Remove Thousand Oaks Related Topics
Pricing Screening Incubator Writing Technical Review Entertainment Marketing Equity Startup Develop More Related Topics >
article thumbnail

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Xconomy

JUNE 10, 2016

—At the annual BIO conference, which gathered in San Francisco for the first time since cops battled street protesters in 2004, industry bigwigs took to the stage to defend themselves. Not against street riots this time, but against political, financial, and social pressures that are changing the way America pays for drugs.

Incubator 67
Incubator Thousand Oaks Screening Pricing 67
article thumbnail

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More

Xconomy

AUGUST 5, 2016

That story and plenty more—including a bevy of gene therapy news, the latest on the Zika virus, and a long-awaited presentation from an embattled CEO—below: —Theranos CEO Elizabeth Holmes spoke at a conference for laboratory scientists this week in Philadelphia. Regeneron is paying $25 million upfront.

News 40
News Thousand Oaks Pricing Report 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 5,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024